BALA CYNWYD, Pa., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith, LLC announces that it is investigating the legal ramifications of the proposed acquisition of PharmaNet Development Group, Inc. ("PharmaNet" or the "Company") (Nasdaq:PDGI) by affiliates of JLL Partners, Inc. ("JLL"). JLL has offered PharmaNet shareholders $5.00 a share for their stock. The deal appears to be undervalued given the fact that less than a year ago the stock was trading at over $41.00 a share and as recently as September 2008, PharmaNet stock traded at over $23.00 a share.
If you are a PharmaNet shareholder and wish to discuss the legal ramifications of the proposed acquisition by JLL, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.